Results of Operations and Financial Condition, Financial Statements and

ITEM 2.02. Results of Operations and Financial Condition

On May 12, 2014, Osiris Therapeutics, Inc. ("Osiris") issued a press release
announcing its financial results for the quarterly period ended March 31, 2014,
as well as other information. A copy of the Press Release, including the
accompanying Financial Tables, as issued on May 12, 2014, is set forth in
Exhibit 99.1 hereto.

The information included herein, including Exhibit 99.1 furnished herewith,
shall not be deemed to be "filed" for purposes of Section 18 of the Securities
Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that section, nor shall it be incorporated by reference into any
filing pursuant to the Securities Act of 1933, as amended, or the Exchange Act,
regardless of any incorporation by reference language in any such filing, except
as expressly set forth by specific reference in such filing.

Information presented in this Current Report on Form 8-K may contain
forward-looking statements and certain assumptions upon which such
forward-looking statements are in part based. Forward-looking statements are
subject to known and unknown risks and uncertainties and are based on
potentially inaccurate assumptions that could cause actual results to differ
materially from those expected or implied by the forward-looking statements.
Risks and uncertainties that could cause our actual results to differ materially
from those anticipated in forward-looking statements, include the factors
described in the sections entitled "Risk Factors" in our Annual Report on
Form 10-K filed with the United States Securities and Exchange. You should not
unduly rely on forward-looking statements.